Canada Hearing Loss Disease Treatment Market Size & Outlook
Related Markets
Canada hearing loss disease treatment market highlights
- The Canada hearing loss disease treatment market generated a revenue of USD 373.5 million in 2024 and is expected to reach USD 601.9 million by 2030.
- The Canada market is expected to grow at a CAGR of 8.3% from 2025 to 2030.
- In terms of segment, devices was the largest revenue generating product in 2024.
- Devices is the most lucrative product segment registering the fastest growth during the forecast period.
Hearing loss disease treatment market data book summary
| Market revenue in 2024 | USD 373.5 million |
| Market revenue in 2030 | USD 601.9 million |
| Growth rate | 8.3% (CAGR from 2025 to 2030) |
| Largest segment | Devices |
| Fastest growing segment | Devices |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Devices, Drugs |
| Key market players worldwide | Novartis AG ADR, Frequency Therapeutics, Acousia Therapeutics, Sensorion, Pipeline Therapeutics, Audina Hearing Instruments, Astellas Pharma Inc |
Other key industry trends
- In terms of revenue, Canada accounted for 3.2% of the global hearing loss disease treatment market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. hearing loss disease treatment market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 267.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hearing Loss Disease Treatment Market Scope
Hearing Loss Disease Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Audina Hearing Instruments | View profile | 11-50 | Longwood, Florida, United States, North America | https://www.audina.net/ |
| Pipeline Therapeutics | View profile | 11-50 | San Diego, California, United States, North America | http://www.pipelinetherapeutics.com |
| Sensorion | View profile | 51-100 | Clapiers, Languedoc-Roussillon, France, Europe | https://www.sensorion.com/ |
| Acousia Therapeutics | View profile | 1-10 | Tübingen, Baden-Wurttemberg, Germany, Europe | http://www.acousia.com/ |
| Frequency Therapeutics | View profile | 51-100 | Lexington, Massachusetts, United States, North America | http://www.frequencytx.com/index.php |
| Astellas Pharma Inc | View profile | 14484 | 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 | http://www.astellas.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Canada hearing loss disease treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hearing loss disease treatment market will help companies and investors design strategic landscapes.
Devices was the largest segment with a revenue share of 99.09% in 2024. Horizon Databook has segmented the Canada hearing loss disease treatment market based on devices, drugs covering the revenue growth of each sub-segment from 2018 to 2030.
According to a study published by Canada Statistics in August 2019, an estimated 4.6 million adults in the Canada suffer from mild hearing loss for speech frequency between 0.5 kHz and 4 kHz. To address the situation, market players in Canada are focusing on implementation of health campaigns along with new product launches and technological developments for hearing aids.
For instance, in March 2023, Widex Canada announced the launch of its new campaign to raise awareness about tinnitus. The company introduced a free e-book, which offers information about better management of tinnitus and its treatment.
Furthermore, in August 2022, GN Hearing announced the launch of an advanced hearing aid, ReSound OMNIA, in Canada. This newly introduced device is capable of reducing noise by 150%. Moreover, in August 2022, Unitron announced launch of its new Moxi B-RS hearing aids with cutting edge technology.
Reasons to subscribe to Canada hearing loss disease treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada hearing loss disease treatment market databook
-
Our clientele includes a mix of hearing loss disease treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada hearing loss disease treatment market, including forecasts for subscribers. This country databook contains high-level insights into Canada hearing loss disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada hearing loss disease treatment market report size, by product, 2018-2030 (US$M)
Canada Hearing Loss Disease Treatment Market Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
